Back to search

France· FR:66180816

HAEMOPRESSIN 1 mg, poudre et solvant pour solution injectable

A terlipressin product containing acétate de terlipressine, registered in France by ALLIANCE PHARMA (IRLANDE). The same ATC class is registered in 15 of our 19 countries.

ATC H01BA04

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedHAEMOPRESSIN 1 mg, poudre et solvant …ATCH01BA04REGISTER NO.FR:66180816PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Terlipressin is registered in 15 of 19 countries.

Countries holding a registration under ATC H01BA04 (terlipressin), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 9 of them publish a price we can compare per daily dose

Terlipressin · ATC H01BA04

15 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
ACÉTATE DE TERLIPRESSINE
Manufacturer
ALLIANCE PHARMA (IRLANDE)
Country
France (FR)
ATC code
H01BA04
ATC class
Terlipressin
Defined daily dose
12 mg, P
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400957537210
    5 flacon(s) en verre - 5 ampoule(s) en verre de 5 ml

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Terlipressin in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All terlipressin products

Authorised across Europe · EMA

The same active substance is authorised in 12 EEA countries. Names it is sold under:

  • Austria · Glycylpressin, Terlipressinacetat Ever Pharma
  • Bulgaria · Терлипресин Ацетат Ever Pharma
  • Czechia · Remestyp, Terlipresin Acetát Ever Pharma
  • Germany · Glycylpressin, Terlipressinacetat Ever Pharma
  • Spain · Terlipresina Acetato Ever Pharma
  • Hungary · Glypressin
  • Ireland · Terlipressin Acetate Ever Pharma
  • Italy · Glipressina, Terlipressina Acetato Ever Pharma
  • Poland · Terlipressini Acetas Ever Pharma
  • Portugal · Glypressine, Terlipressina Ever Pharma
  • Romania · Acetat De Terlipresină Ever Pharma
  • Slovakia · Remestyp, Terlipresín Ever Pharma

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/77d5c7e8-707d-43c0-b396-2f135aa5af2f
GET /v1/drugs/77d5c7e8-707d-43c0-b396-2f135aa5af2f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "66180816",
  "date_amm": "2009-08-04",
  "type_amm": "Procédure de reconnaissance mutuelle",
  "numero_ue": null,
  "substance": "ACÉTATE DE TERLIPRESSINE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation abrogée",
  "statut_bdm": "Warning disponibilité",
  "forme_pharmaceutique": "poudre et  solvant pour solution injectable",
  "voies_administration": "intraveineuse",
  "etat_commercialisation": "Non commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about terlipressin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.